Middle East and Africa In-vitro Diagnostics Market Growth, Size, Trends, Share and Future Outlook
Middle East and Africa In-vitro Diagnostics Market Size– By Product and Service, By Technology, By Application- Regional Outlook, Competitive Strategies and Segment Forecast to 2033
| Published: Jan-2024 | Report ID: HLCA2413 | Pages: 1 - 159 | Formats*: |
| Category : Healthcare | |||
Middle East and Africa In-vitro Diagnostics Market Introduction and Overview
According to SPER Market Research, the Middle East and Africa In-vitro Diagnostics Market is estimated to reach USD 7.07 billion by 2033 with CAGR of 5.76%.
The report includes an in-depth analysis of the Middle East and Africa In-vitro Diagnostics Market, including market size and trends, product mix, applications, and supplier analysis. The term "in vitro" refers to "in glass," meaning that these tests are typically conducted in test tubes and related equipment as opposed to in vivo testing, which are conducted within the body. In precision medicine, in vitro diagnostics can also be used to identify patients who are most likely to benefit from specific medications or treatments. Next-generation sequencing tests, which examine a person's DNA to find genomic variants, may be one of these in-vitro diagnostic procedures.
- February 2022: The World Health Organization (WHO) approved TrinScreen HIV, Trinity Biotech plc's new HIV screening solution. In less than 12 minutes, TrinScreen HIV can provide results from a fingerstick blood sample. In a multi-center clinical trial that the company conducted in Africa in 2020, as well as in an independent evaluation sponsored by the World Health Organization, the test demonstrated strong performance.
- March 2022: Medical Diagnostech, a South African company that develops and produces lateral flow quick diagnostic test kits, and Audere partnered together. Through this collaboration, the MD SARS-CoV-2 antigen instrument from Medical Diagnostech and the HealthPulse digital companion app from Audere will be paired.
Market Opportunities and Challenges
Significant advancements have been made in the clinical laboratory market as a result of the introduction of new technologies and the expanding presence of independent commercial laboratories. As a result, there has been a noticeable trend away from hospital-based laboratories and toward independent labs with technological breakthroughs. Point of care testing (POCT) and in-vitro diagnostics (IVD) are predicted to develop significantly. The need for quick, affordable, and user-friendly POCT instruments for the diagnosis of infectious diseases has increased significantly. Adoption of managed clinical services in the region's hospitals, smart labs-as-a-service for automation of laboratory services, and the requirement for next-generation sequencing testing for genetic testing are other key sectors with substantial growth potential.
The Middle East and Africa's intricate regulatory framework can make it difficult to reimburse in-vitro testing equipment. Furthermore, the lack of capital-intensive equipment in the region's healthcare facilities restricts the use and uptake of cutting-edge items. For example, a report released by the Southern African Research & Innovation Management Association states that South Africa has a limited medical device business, and that neither the physician nor the patient is aware of the device's cost. Additionally, there are no incentives available to reduce the device's cost. Therefore, it is projected that a lack of knowledge regarding reimbursement programs will restrict market expansion.
Market Competitive Landscape
There are multiple significant companies in Middle East and Africa In-vitro Diagnostics market which is highly competitive. Currently, a few significant firms dominate the GCC industry in terms of market share. Some of major players are Abbott Laboratories, Danaher Corporation, Becton, Dickinson and Company, BioMerieux SA, Siemens Healthineers, Thermo Fischer Scientific Inc., Seegene Inc., Sysmex Corporation and various others. These corporations primarily oversee distribution through their branch offices or distributors who conduct business both domestically and internationally.
Scope of the Report:
| Report Metric | Details |
| Market size available for years | 2019-2033 |
| Base year considered | 2022 |
| Forecast period | 2023-2033 |
| Segments covered | By Product and Service, By Technology, By Application |
| Regions covered | GCC5, South Africa, Rest of Middle East & Africa |
| Companies Covered | Abbott Laboratories, Danaher Corporation, Becton, Dickinson and Company, BioMerieux SA, Siemens Healthineers, Thermo Fischer Scientific Inc., Seegene Inc., Sysmex Corporation and various others. |
COVID-19 Impact on Middle East and Africa In-vitro Diagnostics Market
The COVID-19 pandemic had a major effect on the in-vitro diagnostics market because of the rise in demand for IVD kits and reagents to diagnose SARS-CoV-2 virus infection in the local population quickly and accurately. The WHO reported in 2022 that the number of laboratories able to detect COVID-19 had increased from two to over 900 thanks to a number of initiatives, including the establishment of the Regional Centre of Excellence for Genomic Surveillance and Bioinformatics in South Africa in partnership with the SANBI at the University of Western Cape. African attempts at genetic sequencing were also aided by WHO.
Key Target Audience:
- Clinical Laboratories and Pathology Centers
- Hospitals and Healthcare Institutions
- Government Health Departments
- IVD Manufacturers and Suppliers
- Pharmaceutical Companies
- Research and Academic Institutions
- Healthcare IT Companies
- Health Insurance Providers
- Patients and Caregivers
- Government and Non-Governmental Organizations (NGOs)
- Telehealth and Remote Monitoring Providers
Our in-depth analysis of the Middle East and Africa In-vitro Diagnostics Market includes the following segments:
| By Product and Service: |
|
| By Technology: |
|
| By Application: |
|
Key Topics Covered in the Report:
- Middle East and Africa In-vitro Diagnostics Market Size (FY’2023-FY’2033)
- Overview of Middle East and Africa In-vitro Diagnostics Market
- Segmentation of Middle East and Africa In-vitro Diagnostics Market By Product and Service (Instruments, Reagents and Kits, Software and Services)
- Segmentation of Middle East and Africa In-vitro Diagnostics Market By Technology (Blood Glucose Self-Monitoring, Clinical Chemistry, Coagulation and Haemostasis, Haematology, Immunoassay/Immunochemistry, Microbiology, Molecular Diagnostics, Urinalysis, Others)
- Segmentation of Middle East and Africa In-vitro Diagnostics Market By Application (Autoimmune Diseases, Cardiology, Diabetes, Infectious Diseases, Nephrology, Oncology, Others)
- Statistical Snap of Middle East and Africa In-vitro Diagnostics Market
- Expansion Analysis of Middle East and Africa In-vitro Diagnostics Market
- Problems and Obstacles in Middle East and Africa In-vitro Diagnostics Market
- Competitive Landscape in the Middle East and Africa In-vitro Diagnostics Market
- Impact of COVID-19 and Demonetization on Middle East and Africa In-vitro Diagnostics Market
- Details on Current Investment in Middle East and Africa In-vitro Diagnostics Market
- Competitive Analysis of Middle East and Africa In-vitro Diagnostics Market
- Prominent Players in the Middle East and Africa In-vitro Diagnostics Market
- SWOT Analysis of Middle East and Africa In-vitro Diagnostics Market
1. Introduction
1.1. Scope of the report1.2. Market segment analysis
2. Research Methodology
2.1. Research data source2.1.1. Secondary Data2.1.2. Primary Data2.1.3. SPER’s internal database2.1.4. Premium insight from KOL’s2.2. Market size estimation2.2.1. Top-down and Bottom-up approach2.3. Data triangulation
3. Executive Summary
4. Market Dynamics
4.1. Driver, Restraint, Opportunity and Challenges analysis4.1.1. Drivers4.1.2. Restraints4.1.3. Opportunities4.1.4. Challenges4.2. COVID-19 Impacts of the Middle East And Africa In-vitro Diagnostics Market
5. Market variable and outlook
5.1. SWOT Analysis
5.1.1. Strengths5.1.2. Weaknesses5.1.3. Opportunities5.1.4. Threats5.2. PESTEL Analysis5.2.1. Political Landscape5.2.2. Economic Landscape5.2.3. Social Landscape5.2.4. Technological Landscape5.2.5. Environmental Landscape5.2.6. Legal Landscape5.3. PORTER’s Five Forces5.3.1. Bargaining power of suppliers5.3.2. Bargaining power of buyers5.3.3. Threat of Substitute5.3.4. Threat of new entrant5.3.5. Competitive rivalry5.4. Heat Map Analysis
6. Competitive Landscape
6.1. Middle East And Africa In-vitro Diagnostics Market Manufacturing Base Distribution, Sales Area, Product Type6.2. Mergers & Acquisitions, Partnerships, Product Launch, and Collaboration in Middle East And Africa In-vitro Diagnostics Market
7. Middle East And Africa In-vitro Diagnostics Market, By Product and Service, 2019-2033 (USD Million)
7.1. Middle East And Africa In-vitro Diagnostics Market Value Share and Forecast, By Product and service, 2023-20337.2. Instruments7.3. Reagents and Kits7.4. Software and Services
8. Middle East And Africa In-vitro Diagnostics Market, By Technology, 2019-2033 (USD Million)
8.1. Middle East And Africa In-vitro Diagnostics Market Value Share and Forecast, By Technology, 2023-20338.2. Blood Glucose Self-Monitoring8.3. Clinical Chemistry8.4. Coagulation and Haemostasis8.5. Haematology8.6. Immunoassay/Immunochemistry8.7. Microbiology8.8. Molecular Diagnostics8.9. Urinalysis8.10. Others
9. Middle East And Africa In-vitro Diagnostics Market, By Application, 2019-2033 (USD Million)
9.1. Middle East And Africa In-vitro Diagnostics Market Value Share and Forecast, By Application, 2023-20339.2. Autoimmune Diseases9.3. Cardiology9.4. Diabetes9.5. Infectious Diseases9.6. Nephrology9.7. Oncology
9.8. Others
10. Middle East And Africa In-vitro Diagnostics Market Forecast, 2019-2033 (USD Million)
10.1. Middle East And Africa In-vitro Diagnostics Market Size and Market Share
11. Middle East And Africa In-vitro Diagnostics Market, By Product and Service, 2019-2033 (USD Million)
11.1. Middle East And Africa In-vitro Diagnostics Market Size and Market Share By Product and Service (2019-2026)11.2. Middle East And Africa In-vitro Diagnostics Market Size and Market Share By Product and Service (2027-2033)
12. Middle East And Africa In-vitro Diagnostics Market, By Technology, 2019-2033 (USD Million)
12.1. Middle East And Africa In-vitro Diagnostics Market Size and Market Share By Technology (2019-2026)12.2. Middle East And Africa In-vitro Diagnostics Market Size and Market Share By Technology (2027-2033)
13. Middle East And Africa In-vitro Diagnostics Market, By Application, 2019-2033 (USD Million)
13.1. Middle East And Africa In-vitro Diagnostics Market Size and Market Share By Application (2019-2026)13.2. Middle East And Africa In-vitro Diagnostics Market Size and Market Share By Application (2027-2033)
14. Middle East And Africa In-vitro Diagnostics Market, By Region, 2019-2033 (USD Million)
14.1. Middle East And Africa In-vitro Diagnostics Market Size and Market Share By Region (2019-2026)14.2. Middle East And Africa In-vitro Diagnostics Market Size and Market Share By Region (2027-2033)14.2.1. GCC14.2.2. South Africa14.2.3. Rest of Middle East & Africa Source
15. Company Profile
15.1. Abbott Laboratories15.1.1. Company details15.1.2. Financial outlook15.1.3. Product summary15.1.4. Recent developments15.2. Becton, Dickinson and Company15.2.1. Company details15.2.2. Financial outlook15.2.3. Product summary15.2.4. Recent developments15.3. BioMerieux SA15.3.1. Company details15.3.2. Financial outlook15.3.3. Product summary15.3.4. Recent developments15.4. Seegene Inc.15.4.1. Company details15.4.2. Financial outlook15.4.3. Product summary15.4.4. Recent developments15.5. Siemens Healthineers15.5.1. Company details15.5.2. Financial outlook15.5.3. Product summary15.5.4. Recent developments15.6. Thermo Fischer Scientific Inc.15.6.1. Company details15.6.2. Financial outlook15.6.3. Product summary15.6.4. Recent developments15.7. Qiagen N.V15.7.1. Company details15.7.2. Financial outlook15.7.3. Product summary15.7.4. Recent developments15.8 Others
16 List of Abbreviations
17 Reference Links
18 Conclusion
19 Research Scope
SPER Market Research’s methodology uses great emphasis on primary research to ensure that the market intelligence insights are up to date, reliable and accurate. Primary interviews are done with players involved in each phase of a supply chain to analyze the market forecasting. The secondary research method is used to help you fully understand how the future markets and the spending patterns look likes.
The report is based on in-depth qualitative and quantitative analysis of the Product Market. The quantitative analysis involves the application of various projection and sampling techniques. The qualitative analysis involves primary interviews, surveys, and vendor briefings. The data gathered as a result of these processes are validated through experts opinion. Our research methodology entails an ideal mixture of primary and secondary initiatives.
Frequently Asked Questions About This Report
Middle East and Africa In-vitro Diagnostics Market is projected to reach USD 7.07 billion by 2033, growing at a CAGR of 5.76% during the forecast period.
Middle East and Africa In-vitro Diagnostics Market size from 2022. The Market is expected to reach USD 7.07 billion by 2033, at a CAGR of 5.76% during the forecast period.
Middle East and Africa In-vitro Diagnostics Market CAGR of 5.76% during the forecast period.
You can get the sample pages by clicking the link - Click Here
Middle East and Africa In-vitro Diagnostics Market size is 7.07 billion from 2023 to 2033.
Middle East and Africa In-vitro Diagnostics Market Segment is covered By Product and Service, By Technology, By Application.
The MEA is anticipated to have the highest market share in the Middle East and Africa In-vitro Diagnostics Market.
"The key players in the market include Companies Covered Abbott Laboratories, Danaher Corporation, Becton, Dickinson and Company, BioMerieux SA, Siemens Healthineers, Thermo Fischer Scientific Inc., Seegene Inc., Sysmex Corporation and various others."
The term "in vitro" refers to "in glass," meaning that these tests are typically conducted in test tubes and related equipment as opposed to in vivo testing, which are conducted within the body.
PLACE AN ORDER
Year End Discount
Sample Report
Pre-Purchase Inquiry
NEED CUSTOMIZATION?
Request CustomizationCALL OR EMAIL US
100% Secure Payment
Related Reports
Have a glance of the Report
Our Global Clients
Our data-driven insights have influenced the strategy of 200+ reputed companies across the globe.
